Skip to the main content.
HUB of
Biotherapeutic
Intelligence™
Protein Manufacturing
Overview

 

Catalog Products
Online Store
HUB of
Biotherapeutic
Intelligence™
See our latest upcoming event.
Tell me moreto Events
HUB of
Biotherapeutic
Intelligence™
Applications
Insights
See our latest upcoming event.
Tell me moreto Events
HUB of
Biotherapeutic
Intelligence™
See our latest upcoming event.
Tell me moreto Events
HUB of
Biotherapeutic
Intelligence™
See our latest upcoming event.
Tell me moreto Events

Company

 

Contact Us

ENGINEERED for the Biotherapeutic Race

Engineered for the biotherapeutic race


The HUB of intelligence

IPA (ImmunoPrecise Antibodies NASDAQ: IPA ) is a biotherapeutic research company that brings industry leading antibody discovery services and complex artificial intelligence technologies together — to lead its pharmaceutical partners into the era of the antibody.

The dynamic duo for antibody discovery. Simply the best combined wet lab + in silico antibody discovery.

Recently ranked by one of the pharmaceutical industry’s most trusted independent market research sources with the highest score for its antibody service portfolio1, the company is comprised of a hybrid of scientific experts and technologies in biotherapeutic drug discovery. IPA provides highly specialized, full-continuum therapeutic antibody discovery development and wet lab services, with in silico machine intelligence designed to solve the unique challenges big data processing poses pharmaceutical companies.

Biotherapeutic Inteligence
Hub of biotherapeutic intelligence

Uniting human and machine learning with the best combination of wet lab + in silico platforms, technologies, and people to conquer deadly and debilitating diseases.

IPA Excellence
Proven history of excellence

Trusted track record of scientific rigor and robust outcomes with diverse candidate pools and libraries…

IPA Transformative Technology
Dedicated to transformative technology

IPA builds on reputation by delivering a dynamic new approach to biological intelligence that translates into meaningful knowledge…

IPAextensionlabco
Extension of your lab

IPA is proud of high customer satisfaction built on trust in delivering customized programs that succeed in solving complex target challenges…

IPA Function-First Focus
Function-First focus

Proficiency in identifying clinically-relevant antibodies.

IPApartnershipco
Licensing and partnership

With subsidiary partner Talem, access a VAULT of next-generation, fully-human antibody programs to streamline your path to the clinic…

1. ROOTS 2022: Antibody Discovery Services and Platforms Market (4th Edition), 2021-2035; p.118

Welcome to the era of the antibody.

On the cutting edge of everything.

Learn more

Connect with IPA